Ranjala Ratnayake

8PUBLICATIONS
30CO-AUTHORS
Biologically active moleculesCancer diagnosisMolecular targetsProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 29, 2026
Biosynthetic origin of anticancer dolastatin 15 reveals a noncanonical NRPS architecture enabling 2-keto acid activation.

|Apr 30, 2026
Natural Products Inspired Scaffold Diversification Leads to Unnatural Molecular Warhead and Covalent Strategy to Modulating Protein Function through Electrophilic Bromine Transfer.

|Dec 02, 2024
Progress in the discovery and development of anticancer agents from marine cyanobacteria.

Hendrik Luesch, Emma K Ellis, Qi-Yin Chen

|Dec 11, 2023
Epigenetic Small-Molecule Screen for Inhibition and Reversal of Acinar Ductal Metaplasia in Mouse Pancreatic Organoids.

Kalina R Atanasova, Corey M Perkins, Ranjala Ratnayake

|Nov 24, 2023
Discovery and Anti-Inflammatory Activity of a Cyanobacterial Fatty Acid Targeting the Keap1/Nrf2 Pathway.

Fatma H Al-Awadhi, Emily F Simon, Na Liu

|Mar 10, 2022
Anti-Inflammatory Dysidazirine Carboxylic Acid from the Marine Cyanobacterium Caldora sp. Collected from the Reefs of Fort Lauderdale, Florida.

Sarath P Gunasekera, Sofia Kokkaliari, Ranjala Ratnayake

Pageof 2

Frequent Collaborators

7 joint publications

Hendrik Luesch

4 joint publications

Valerie J Paul

2 joint publications

Qi-Yin Chen

1 joint publications

Yuvixza Lizarme-Salas